A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

NCT01461993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2499

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaccines
Meningococcal Vaccines

Interventions

BIOLOGICAL: rLP2086 and Gardasil
BIOLOGICAL: rLP2086
BIOLOGICAL: Gardasil

Sponsor

Pfizer